FREQUENTLY ASKED QUESTIONS

Prior to making an application or query please read our FAQs

Yes you can resubmit the proposal if applicable to do so in the next similar round. However rather than make an identical application we would expect you to make amendments to strengthen any future submission from any feedback Rosetrees may have provided or through any internal discussion.

Who can apply?

A biomedical scientist working in clinically relevant medical research is acceptable. The clinician or biomedical scientist must have an established academic track record and be in a tenured position at least for the duration of the award.

Both lead applicants should be UK based and preferably from the same institution. Overseas collaborations can assist if this enhances the research but the funding can only go to the UK based lead institution.

A PI from the hospital trust is acceptable and presumed they will be medicine lead.

Yes, as long as the lead institution is agreed and this becomes that institution’s one and only application. The funding must be managed by that lead institution.

Your application would have to be selected on behalf of the whole institution.

The past ID winners have all been in tenured position and the applicant must be in-contract for at least the duration of the project.

What collaborations are acceptable?

Yes, it is acceptable.

Yes, overseas collaborations are possible.

Will my project fit the remit of this call?

Line of sight to clinic is essential for a successful application. It does not have to result in patient benefit by the end of the grant but must be a clear plan on how this will be achieved within 5-10 years post-grant. 

The projects are chosen on their own merits and interdisciplinarity and not biased towards any particular area of medicine.

The quality of the project and the potential impact on human health is of highest importance. We usually fund research that affects UK patients and some of our research is from tropical medicine which may affect a small population in the UK with an impact worldwide. There is therefore scope if a small UK population will also benefit.

Yes, it can have elements of translational research in pre-clinical animal models

What can I include in the costing?

Yes, it is the same.

The grant offer is for £330,000 over 3 years (i.e. £110,000 p.a.) and grants must be for a 3 year period.

Payments are made in advance in 6 monthly instalments from the start of the project, as soon as all the relevant paperwork and agreement is in place. After the first 6 months, subsequent payments will be made on receipt of a progress report.

Depending on the quality of the applications we have funded up to 3 ID prizes. One fully funded by RT, one with a co-donor and one part funded (50%) with funds made up by the university.  However this is a decision made by our advisory panel on a yearly basis.

We do fund clinical time. However, this will come out of the total £330,000 award.

The round will open on the 1st July  when the ‘Seedcorn 2024’ scheme will be available to start an online submission through the website and when logged into a Rosetrees Flexigrant account. The round will close at 17:00 on the 9th September, and you will not be able to access this link before or after these dates.
 
Masters, PhD students and early career post-docs are eligible to apply as the lead applicant. However, the round is very competitive so it is essential that students and early-career researchers apply with established co-applicants.
Please check the website initially and if you would like further clarification, then please e-mail info@rosetrees.org.uk and we can arrange for you to speak to someone.
Yes, on the basis that both proposals are completely separate.
Yes there is no restriction if you make a submission into this seedcorn round, and have or plan to submit an application in another funding round. However, we do not allow multiple submissions into the same funding round.
As the principal applicant, as long as you are able to work at a UK institution for the whole duration of the project, then you will be eligible to apply.
Salaries of the researchers (non-tenured positions including postdocs and technicians), consumables, small benchtop equipment and patient travel expenses are the main eligible costs. We don’t fund institutional overheads, large equipment or capital spending, conference costs, technology transfer fees and tuition fees. Publication costs can be included if they are open-access, and we don’t fund apprenticeship levies.
We plan on communicating to successful applicants in late 2024/ early 2025 and the funding will be available shortly thereafter. We can start grants as soon as award letters have been signed by the institution and we have received various confirmations and information required.
Due to the high volume of applications, we receive we are unable to provide individual feedback to applications that do not progress beyond the triage stage. However, if your application progresses beyond the triage stage and is rejected, we will send you feedback from external reviewers. If you are able to revise and amend your application based on this feedback, then you can resubmit your application in a subsequent grant round.
The submit button will appear when all co-applicant and collaborators have completed their participation. To complete their participation, all co-applicants and collaborators must login to their Flexigrant account and click the ‘Finish Contribution’ button.
We are unable to accept submissions after the deadline date.